Press Releases
Curiosity + Expertise = Innovation.
Catch up on all the latest Gateway Analytical news and press releases, see a list of events we’ll be attending, and read our original content discussing our latest services offerings and instruments in the articles below.
Gateway Analytical to Attend The Alliance for Regenerative Medicine’s Cell & Gene ‘Meeting on the Mesa’ 2023
Gateway Analytical is excited to attend The Alliance for Regenerative Medicine’s Cell & Gene ‘Meeting on the Mesa’, the premier event for advancing research into
Gateway Analytical at CPHI Barcelona 2023: Where Science Meets Innovation
Gateway Analytical at CPHI Barcelona 2023: Where Science Meets Innovation Mark your calendars for October 24-26, 2023, as Gateway Analytical takes center stage at CPHI
Gateway Analytical to Promote Medical Device Testing Services at the 7th Annual Pharmaceutical and Medical Device Manufacturing and Quality Operations Forum
Gateway Analytical announced today that they will be exhibiting at the 7th Annual Pharmaceutical and Medical Device Manufacturing and Quality Operations Forum in New Orleans, Louisiana,
DDL 2012: Assessment of Drugs and Carrier PSD in a Commercial Combinational Dry Powder Inhaler Post Multistage Cascade Impaction Analysis by Raman Imaging
December 07, 2012
2013 AAPS Annual Meeting Recap
For the third consecutive year Gateway had the pleasure of exhibiting at the AAPS Annual Meeting, which was held this year in San Antonio, at the
Gateway Analytical Acquires RapID System to Meet Growing Market Demand
PITTSBURGH, January, 21 2014 — Gateway Analytical announced today that they have acquired the RapID SPE-ls raman.ID + metal.ID® system, the latest technology in automated
RDD 2012: Investigation of the Microstructure of Combination Dry Powder Inhaler Formulations by Atomic Force Microscopy and Raman Chemical Imaging
May 20, 2012 The microstructure of combination DPI formulations is complex and is related to the surface interfacial interactions between components of the formulation, which define the structure and thereby performance of the formulation (1, 2, 3). Previous studies have attempted to investigate the microstructure of combination DPI formulations using…
Gateway Analytical Receives Controlled Substance Registration Certificate from the Drug Enforcement Administration
Gateway Analytical is proud to announce that we have obtained our Controlled Substance Registration Certificate issued by the United States Department of Justice Drug Enforcement
Gateway Analytical Relocates to New Facility and Expands Capabilities
Facility Opens New Doors for Foreign Particulate Analysis and Identification Needs of the Global Pharmaceutical, Medical Device and Materials Industries. Pittsburgh, PA (August 29, 2016) –
DDL and Gateway Analytical Announce Joint Agreement
EDEN PRAIRIE, MN (PRWEB) SEPTEMBER 18, 2017 – DDL, Inc. and Gateway Analytical announced they have entered into a joint agreement to offer complementary testing services
Gateway Analytical to Present on Formulation Development and Establishing Bioequivalence in Drug Products
Gateway Analytical announced today that they will be presenting on chemically-specific particle analysis in addition to exhibiting at the upcoming Bioequivalence: Intersection between Science & Regulatory Conference
Gateway Analytical Promotes Expertise in Foreign Particulate Testing Services at the 2016 PDA Universe of Pre-filled Syringes and Injection Devices Conference
Gateway Analytical will exhibit at the 2016 PDA Universe of Pre-filled Syringes and Injection Devices in Huntington Beach, California on October 17-18, 2016. The conference
Gateway Analytical Achieves the Prestigious ASCLD/LAB-International Accreditation for Forensic Trace Evidence Testing!
We are now one (1) of only two (2) private labs in the country that is accredited to this standard for trace evidence, and we are
Extractables
& Leachables
Container Closure
Integrity Testing
Particulate
Analysis
Medical Device
Analysis
Early-Phase Development
Empowering Your Journey Toward Enhanced Patient Care
Covering every stage of the drug development journey with our state-of-the-art, FDA-inspected, cGMP-compliant facilities designed to minimize bottlenecks and maximize success.